The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

30 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery and analgesic evaluation of 8-chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione as a novel potent d-amino acid oxidase inhibitor.EBI
Shanghai Jiao Tong University
D-Amino acid oxidase inhibitors based on the 5-hydroxy-1,2,4-triazin-6(1H)-one scaffold.EBI
Johns Hopkins University
Identification of Novel D-Aspartate Oxidase Inhibitors by in Silico Screening and Their Functional and Structural Characterization in Vitro.EBI
Kitasato University
6-Hydroxy-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Novel D-Amino Acid Oxidase Inhibitors.EBI
Johns Hopkins University
Structure-Metabolism Relationships in the Glucuronidation of d-Amino Acid Oxidase Inhibitors.EBI
Johns Hopkins University
Synthesis of kojic acid derivatives as secondary binding site probes of D-amino acid oxidase.EBI
Johns Hopkins University
Structural, kinetic, and pharmacodynamic mechanisms of D-amino acid oxidase inhibition by small molecules.EBI
Sunovion Pharmaceuticals
Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema: part 2.EBI
Astellas Pharma
4-Hydroxypyridazin-3(2H)-one derivatives as novel D-amino acid oxidase inhibitors.EBI
Astellas Pharma
Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.EBI
Kitasato University
Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema.EBI
Astellas Pharma
Synthesis and SAR of 1-hydroxy-1H-benzo[d]imidazol-2(3H)-ones as Inhibitors of D-Amino Acid Oxidase.EBI
TBA
The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1).EBI
Pharmaxis
Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors.EBI
Abbott Healthcare Products
The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors.EBI
Merck Sharp & Dohme
Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3.EBI
Pharmaxis
Structural basis for potent inhibition of d-amino acid oxidase by thiophene carboxylic acids.EBI
Tokushima University
Discovery of d-amino acid oxidase inhibitors based on virtual screening against the lid-open enzyme conformation.EBI
Hungarian Academy Of Sciences
Discovery of isatin and 1H-indazol-3-ol derivatives as d-amino acid oxidase (DAAO) inhibitors.EBI
Hungarian Academy Of Sciences
3-Amidoquinuclidine derivatives: synthesis of compounds and inhibition of butyrylcholinesterase.BDB
University Of Zagreb
1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.BDB
Stanford University
Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy.BDB
The Weizmann Institute Of Science
Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors.BDB
Aventis Pharma